ANDA 216996, held by Nanjing King Friend. Calcitonin Salmon.
As of Nov 16, 2026, ANDA 216996 (Calcitonin-Salmon), held by Nanjing King Friend, was first approved by FDA on Oct 29, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 29, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Calcitonin-Salmon200 IU/ML ยท injectable;injection | Calcitonin Salmon | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters